PANOVA-3 Trial on TTFields + GnP in LAPC: ESMO GI 2025 The PANOVA-3 trial (NCT03377491) at ESMO GI 2025 showed that TTFields + GnP improves pain, symptoms, and quality of life in LAPC.

ESMO GI 2025 Highlights: PANOVA-3 Trial on TTFields + GnP in Unresectable LAPC
@myesmo.bsky.social

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMOGI25 #PANOVA3 #LAPC

Novocure Announced Positive Topline Results from Phase 3 PANOVA-3 Trial - OncoDaily Novocure Announced Positive Topline Results from Phase 3 PANOVA-3 Trial / cancer, Novocure, OncoDaily, Oncology, PANOVA-3, PANOVA-4

Novocure Announced Positive Topline Results from Phase 3 PANOVA-3 Trial

oncodaily.com/insight/novo...

#Cancer #Novocure #OncoDaily #Oncology #PANOVA3 #PANOVA4 #Medicine #Health